Results 171 to 180 of about 571,282 (185)

Deep wavelet scattering orthogonal fusion network for glioma IDH mutation status prediction

Computers in Biology and Medicine, 2023
International audienceAccurately predicting the isocitrate dehydrogenase (IDH) mutation status of gliomas is greatly significant for formulating appropriate treatment plans and evaluating the prognoses of gliomas. Although existing studies can accurately
Yuemin Zhu, Rongpin Wang, Lihui Wang
exaly   +2 more sources

Swin Transformer Improves the IDH Mutation Status Prediction of Gliomas Free of MRI-Based Tumor Segmentation

Journal of Clinical Medicine, 2022
Background: Deep learning (DL) could predict isocitrate dehydrogenase (IDH) mutation status from MRIs. Yet, previous work focused on CNNs with refined tumor segmentation.
Jiangfen Wu, Yiqing Shen, Xianrong Qi
exaly   +2 more sources

IDH mutation and 1p19q codeletion distinguish two radiological patterns of diffuse low-grade gliomas

Journal of Neuro-Oncology, 2017
International audienceDiffuse low-grade gliomas (DLGG) prognosis is variable, depending on several factors, including the isocitrate dehydrogenase (IDH) mutation and the 1p19q codeletion.
Florence Castan, Hugues Duffau, Jeremy Deverdun   +2 more
exaly   +2 more sources

The prognostic IDH1 R132 mutation is associated with reduced NADP+-dependent IDH activity in glioblastoma [PDF]

Acta Neuropathologica, 2010
Somatic mutations in the isocitrate dehydrogenase 1 gene (IDH1) occur at high frequency in gliomas and seem to be a prognostic factor for survival in glioblastoma patients.
Cornelis J F van Noorden, Alberto Bardelli, Simona Lamba   +2 more
exaly   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

Pharmacoresistant seizures and IDH mutation in low-grade gliomas.

Neuro-Oncology Advances, 2021
Yoshie Umemura, Jessica Flynn, Edward Avila   +2 more
exaly  

Prediction of IDH mutation status of glioma based on terahertz spectral data

Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2023
Pei Yang, Rui Tao, Shaowen Zheng
exaly  

The Association between Whole-Brain MR Spectroscopy and IDH Mutation Status in Gliomas

Journal of Neuroimaging, 2020
Andrew A Maudsley, Mohammed Goryawala
exaly  

Prognostic significance of IDH mutation in adult low-grade gliomas: a meta-analysis

Journal of Neuro-Oncology, 2013
Changxiang Yan, Hairui Sun
exaly  

Diagnostic advantage of double immunohistochemistry using two mutation-specific anti-IDH antibodies (HMab-1 and MsMab-1) in gliomas

Brain Tumor Pathology, 2015
Yukinari Kato, Shingo Takano, Akira Matsumura   +2 more
exaly  

IDH mutation and MGMT promoter methylation are associated with the pseudoprogression and improved prognosis of glioblastoma multiforme patients who have undergone concurrent and adjuvant temozolomide-based chemoradiotherapy

Clinical Neurology and Neurosurgery, 2016
Jianning Zhang
exaly